These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6695610)

  • 21. Environmental and genetic factors in the etiology of Parkinson's disease.
    Barbeau A; Roy M; Cloutier T; Plasse L; Paris S
    Adv Neurol; 1987; 45():299-306. PubMed ID: 3493629
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiological study of Parkinson's disease in Parsis in India.
    Bharucha EP; Bharucha NE
    Adv Neurol; 1993; 60():352-4. PubMed ID: 8420151
    [No Abstract]   [Full Text] [Related]  

  • 23. Pesticides and Parkinson's disease.
    Le Couteur DG; McLean AJ; Taylor MC; Woodham BL; Board PG
    Biomed Pharmacother; 1999 Apr; 53(3):122-30. PubMed ID: 10349500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Speculations on the etiology of Parkinson's disease.
    Calne DB; Duvoisin RC; McGeer E
    Adv Neurol; 1984; 40():353-60. PubMed ID: 6695611
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial aggregation of Parkinson's disease.
    de la Fuente-Fernández R; Calne DB
    N Engl J Med; 2001 Apr; 344(15):1168. PubMed ID: 11302144
    [No Abstract]   [Full Text] [Related]  

  • 26. Parkinson's disease and cancer: insights for pathogenesis from epidemiology .
    D'Amelio M; Ragonese P; Sconzo G; Aridon P; Savettieri G
    Ann N Y Acad Sci; 2009 Feb; 1155():324-34. PubMed ID: 19250224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etiology of Parkinson's disease. The role of environment and heredity.
    De Michele G; Filla A; Volpe G; Gogliettino A; Ambrosio G; Campanella G
    Adv Neurol; 1996; 69():19-24. PubMed ID: 8615128
    [No Abstract]   [Full Text] [Related]  

  • 28. A susceptibility gene for late-onset idiopathic Parkinson's disease.
    Hicks AA; Pétursson H; Jónsson T; Stefánsson H; Jóhannsdóttir HS; Sainz J; Frigge ML; Kong A; Gulcher JR; Stefánsson K; Sveinbjörnsdóttir S
    Ann Neurol; 2002 Nov; 52(5):549-55. PubMed ID: 12402251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clues from epidemiology of Parkinson's disease.
    Marttila RJ; Rinne UK
    Adv Neurol; 1987; 45():285-8. PubMed ID: 3493627
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiology of Parkinson's disease.
    Khandhar SM; Marks WJ
    Dis Mon; 2007 Apr; 53(4):200-5. PubMed ID: 17586326
    [No Abstract]   [Full Text] [Related]  

  • 31. [The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].
    Hattori N; Kubo S
    Rinsho Shinkeigaku; 2007 Nov; 47(11):774-8. PubMed ID: 18210796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of genetics in the cause of Parkinson's disease.
    Duvoisin RC
    Mov Disord; 1998; 13 Suppl 1():7-12. PubMed ID: 9613712
    [No Abstract]   [Full Text] [Related]  

  • 33. [Etiology and pathogenesis of parkinson's disease].
    Mizuno Y; Ikebe S; Mochizuki H; Matumine H; Kondo T
    No To Shinkei; 1996 Jan; 48(1):5-17. PubMed ID: 8679319
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathophysiology of Parkinson's disease.
    Bonnet AM; Houeto JL
    Biomed Pharmacother; 1999 Apr; 53(3):117-21. PubMed ID: 10349507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
    Zanetti R; Loria D; Rosso S
    Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders".
    Oertel WH; Trenkwalder C; Gasser T; Schwarz J; Bucher SF; Eichhorn T; Pogarell O; Künig G; Arnold G; Bandmann O
    J Neural Transm Suppl; 1995; 46():325-37. PubMed ID: 8821069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
    Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
    Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
    Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiologic studies of environmental exposures in Parkinson's disease.
    Elbaz A; Tranchant C
    J Neurol Sci; 2007 Nov; 262(1-2):37-44. PubMed ID: 17673256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Parkinson's disease and movement disorders in India: problems and possibilities.
    Muthane UB; Ragothaman M; Gururaj G
    J Assoc Physicians India; 2007 Oct; 55():719-24. PubMed ID: 18173026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.